ABC
IBB icon

Associated Banc-Corp’s iShares Biotechnology ETF IBB Stock Holding History

Associated Banc-Corp’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.07M Sell
24,133
-1,550
-6% -$265K 0.11% 126
2025
Q4 		$4.33M Sell
25,683
-10,169
-28% -$1.65M 0.11% 124
2025
Q3 		$5.18M Sell
35,852
-1,282
-3% -$175K 0.14% 119
2025
Q2 		$4.7M Sell
37,134
-5,948
-14% -$730K 0.13% 123
2025
Q1 		$5.51M Buy
43,082
+279
+0.7% +$37.8K 0.17% 110
2024
Q4 		$5.66M Sell
42,803
-2,173
-5% -$305K 0.17% 109
2024
Q3 		$6.55M Buy
44,976
+2,425
+6% +$351K 0.19% 107
2024
Q2 		$5.84M Buy
42,551
+1,119
+3% +$149K 0.18% 113
2024
Q1 		$5.69M Buy
41,432
+777
+2% +$106K 0.18% 114
2023
Q4 		$5.52M Sell
40,655
-564
-1% -$68.8K 0.19% 113
2023
Q3 		$5.04M Buy
41,219
+735
+2% +$93.5K 0.2% 110
2023
Q2 		$5.14M Sell
40,484
-724
-2% -$94K 0.19% 111
2023
Q1 		$5.32M Sell
41,208
-1,386
-3% -$181K 0.21% 110
2022
Q4 		$5.59M Buy
42,594
+1,224
+3% +$158K 0.23% 105
2022
Q3 		$4.84M Buy
41,370
+803
+2% +$99.7K 0.22% 104
2022
Q2 		$4.77M Sell
40,567
-1,232
-3% -$146K 0.21% 108
2022
Q1 		$5.45M Buy
41,799
+19,907
+91% +$2.59M 0.21% 103
2021
Q4 		$3.34M Buy
21,892
+1,978
+10% +$306K 0.12% 130
2021
Q3 		$3.22M Sell
19,914
-560
-3% -$94.2K 0.13% 126
2021
Q2 		$3.35M Sell
20,474
-64
-0.3% -$9.86K 0.13% 128
2021
Q1 		$2.21M Sell
20,538
-2,568
-11% -$408K 0.14% 125
2020
Q4 		$3.5M Sell
23,106
-4
-0% -$572 0.14% 130
2020
Q3 		$3.13M Buy
23,110
+2,885
+14% +$391K 0.13% 128
2020
Q2 		$2.76M Sell
20,225
-313
-2% -$39.9K 0.12% 138
2020
Q1 		$2.21M Sell
20,538
-559
-3% -$64.4K 0.12% 143
2019
Q4 		$2.54M Sell
21,097
-1,591
-7% -$178K 0.13% 134
2019
Q3 		$2.26M Sell
22,688
-5,156
-19% -$540K 0.12% 137
2019
Q2 		$3.04M Sell
27,844
-1,507
-5% -$160K 0.17% 121
2019
Q1 		$3.28M Sell
29,351
-420
-1% -$46.1K 0.19% 117
2018
Q4 		$2.87M Sell
29,771
-1,033
-3% -$110K 0.19% 122
2018
Q3 		$3.76M Sell
30,804
-718
-2% -$84.5K 0.21% 114
2018
Q2 		$3.46M Buy
31,522
+1
+0% +$107 0.2% 116
2018
Q1 		$3.37M Sell
31,521
-1,193
-4% -$132K 0.19% 115
2017
Q4 		$3.49M Buy
32,714
+2,333
+8% +$249K 0.19% 116
2017
Q3 		$3.38M Sell
30,381
-411
-1% -$43.9K 0.19% 116
2017
Q2 		$3.18M Buy
30,792
+63
+0.2% +$6.21K 0.18% 116
2017
Q1 		$3M Sell
30,729
-69
-0.2% -$6.61K 0.18% 116
2016
Q4 		$2.72M Sell
30,798
-1,128
-4% -$103K 0.17% 117
2016
Q3 		$3.08M Sell
31,926
-651
-2% -$61.9K 0.2% 111
2016
Q2 		$2.79M Sell
32,577
-804
-2% -$72.1K 0.18% 114
2016
Q1 		$2.9M Sell
33,381
-1,506
-4% -$135K 0.19% 111
2015
Q4 		$3.93M Sell
34,887
-462
-1% -$50.1K 0.26% 93
2015
Q3 		$3.57M Buy
35,349
+1,989
+6% +$239K 0.25% 98
2015
Q2 		$4.1M Sell
33,360
-312
-0.9% -$37.3K 0.26% 96
2015
Q1 		$3.85M Sell
33,672
-9
-0% -$993 0.24% 101
2014
Q4 		$3.41M Sell
33,681
-837
-2% -$81.3K 0.21% 109
2014
Q3 		$3.15M Sell
34,518
-906
-3% -$79.5K 0.21% 113
2014
Q2 		$3.04M Sell
35,424
-645
-2% -$50.8K 0.2% 117
2014
Q1 		$2.84M Buy
36,069
+540
+2% +$45K 0.2% 116
2013
Q4 		$2.69M Sell
35,529
-123
-0.3% -$8.73K 0.19% 115
2013
Q3 		$2.49M Sell
35,652
-144
-0.4% -$9.43K 0.2% 114
2013
Q2 		$2.08M Buy
+35,796
New +$2.07M 0.17% 116

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Associated Banc-Corp's IBB Position: Q1 2026 in Review

Associated Banc-Corp reduced its iShares Biotechnology ETF (IBB) stake by 6% in Q1 2026, selling an estimated $265K and leaving 24,133 shares worth $4.07M. The position accounts for 0.11% of the portfolio, ranked #126.

Associated Banc-Corp first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.55M in Q3 2024. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Associated Banc-Corp held 24,133 shares of iShares Biotechnology ETF worth $4.07M as of Q1 2026.
  • Associated Banc-Corp sold 1,550 iShares Biotechnology ETF shares in Q1 2026, an estimated $265K.
  • iShares Biotechnology ETF made up 0.11% of Associated Banc-Corp's portfolio in Q1 2026, its #126 holding.
  • Associated Banc-Corp first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Associated Banc-Corp's iShares Biotechnology ETF position peaked at $6.55M in Q3 2024.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Associated Banc-Corp's 13F filing for Q1 2026, filed 1 May 2026.